Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Dec;56(6):679-82.
doi: 10.1046/j.1365-2125.2003.01933.x.

Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity

Affiliations
Clinical Trial

Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity

Sebastian Härtter et al. Br J Clin Pharmacol. 2003 Dec.

Abstract

Aims: The aim of this study was to assess the influence of concomitant caffeine intake on the pharmacokinetics of oral melatonin, a probe drug for CYP1A2 activity.

Methods: Twelve healthy subjects, six smokers and six nonsmokers, were given melatonin (6 mg) either alone or in combination with caffeine (3 x 200 mg). Blood samples for the analysis of melatonin or caffeine and paraxanthine were taken from 1 h before until 6 h after intake of melatonin. Subjects were genotyped with respect to the CYP1A2*1F (C734A) polymorphism.

Results: When caffeine was coadministered the Cmax and AUC of melatonin were increased on average by 142% (P = 0.001, confidence interval on the difference 44, 80%) and 120% (P < 0.001, confidence interval on the difference 63, 178%), respectively. The inhibitory effect of caffeine was more pronounced in nonsmokers and in individuals with the *1F/*1F genotype.

Conclusion: The results of this study revealed a pronounced effect of caffeine on the bioavailability of orally given melatonin, most probably due to inhibition of CYP1A2 activity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Melatonin serum concentration after oral administration of melatonin alone (closed circles, dotted line) or together with caffeine (3 × 200 mg) given 1 h before and 1 and 3 h after melatonin intake (open squares, solid line). Melatonin serum concentrations were significantly (*P < 0.05; **P < 0.01) higher at all time points between 0.5 and 6 h after melatonin intake when caffeine was coadministered

Similar articles

Cited by

References

    1. Landi MT, Sinha R, Lang NP, Kadlubar FF. Human cytochrome P4501A2. In: Ryder W, editor. Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC; 1999. pp. 173–195. Scientific Publications no. 148. - PubMed
    1. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA. 1989;86:7696–7700. - PMC - PubMed
    1. Bock KW, Schrenk D, Forster A, et al. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics. 1994;4:209–218. - PubMed
    1. Lampe JW, King IB, Li S, et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis. 2000;21:1157–1162. - PubMed
    1. Rost KL, Roots I. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios. Coincidence with plasma clearance and breath test. Clin Pharmacol Ther. 1994;55:402–411. - PubMed

Publication types